34771123|t|Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling Pathways.
34771123|a|Breast cancer (BC) is one of the most common causes of death among women worldwide. Recently, interest in novel approaches for BC has increased by developing new drugs derived from natural products with reduced side effects. This study aimed to treat BC cells with harmine hydrochloride (HMH) to identify its anticancer effects and mechanisms. HMH treatment suppressed cell growth, migration, invasion, and colony formation in MCF-7 and MDA-MB-231 cells, regardless of the hormone signaling. It also reduced the phosphorylation of PI3K, AKT, and mTOR and increased FOXO3a expression. Additionally, HMH treatment increased p38 phosphorylation in MCF-7 cells and activated c-Jun N-terminal kinase (JNK) phosphorylation in MDA-MB-231 cells in a dose-dependent manner, where activated p38 and JNK increased FOXO3a expression. Activated FOXO3a increased the expression of p53, p21, and their downstream proteins, including p-cdc25, p-cdc2, and cyclin B1, to induce G2/M cell cycle arrest. Furthermore, HMH inhibited the PI3K/AKT/mTOR pathway by significantly reducing p-AKT expression in combination with LY294002, an AKT inhibitor. These results indicate that mitogen-activated protein kinases (MAPKs) and AKT/FOXO3a signaling pathways mediate the induction of cell cycle arrest following HMH treatment. Therefore, HMH could be a potential active compound for anticancer bioactivity in BC cells.
34771123	0	21	Harmine Hydrochloride	Chemical	-
34771123	74	87	Breast Cancer	Disease	MESH:D001943
34771123	122	125	AKT	Gene	207
34771123	126	132	FOXO3a	Gene	2309
34771123	153	166	Breast cancer	Disease	MESH:D001943
34771123	168	170	BC	Disease	MESH:D001943
34771123	208	213	death	Disease	MESH:D003643
34771123	220	225	women	Species	9606
34771123	280	282	BC	Disease	MESH:D001943
34771123	404	406	BC	Disease	MESH:D001943
34771123	418	439	harmine hydrochloride	Chemical	-
34771123	441	444	HMH	Chemical	-
34771123	497	500	HMH	Chemical	-
34771123	580	585	MCF-7	CellLine	CVCL:0031
34771123	590	600	MDA-MB-231	CellLine	CVCL:0062
34771123	690	693	AKT	Gene	207
34771123	699	703	mTOR	Gene	2475
34771123	718	724	FOXO3a	Gene	2309
34771123	751	754	HMH	Chemical	-
34771123	775	778	p38	Gene	1432
34771123	798	803	MCF-7	CellLine	CVCL:0031
34771123	824	847	c-Jun N-terminal kinase	Gene	5599
34771123	849	852	JNK	Gene	5599
34771123	873	883	MDA-MB-231	CellLine	CVCL:0062
34771123	934	937	p38	Gene	1432
34771123	942	945	JNK	Gene	5599
34771123	956	962	FOXO3a	Gene	2309
34771123	985	991	FOXO3a	Gene	2309
34771123	1020	1023	p53	Gene	7157
34771123	1025	1028	p21	Gene	644914
34771123	1073	1078	cdc25	Gene	995
34771123	1082	1086	cdc2	Gene	983
34771123	1092	1101	cyclin B1	Gene	891
34771123	1150	1153	HMH	Chemical	-
34771123	1173	1176	AKT	Gene	207
34771123	1177	1181	mTOR	Gene	2475
34771123	1218	1221	AKT	Gene	207
34771123	1253	1261	LY294002	Chemical	MESH:C085911
34771123	1266	1269	AKT	Gene	207
34771123	1355	1358	AKT	Gene	207
34771123	1359	1365	FOXO3a	Gene	2309
34771123	1438	1441	HMH	Chemical	-
34771123	1464	1467	HMH	Chemical	-
34771123	1535	1537	BC	Disease	MESH:D001943
34771123	Association	MESH:D001943	2309
34771123	Positive_Correlation	2309	891
34771123	Positive_Correlation	2309	995
34771123	Positive_Correlation	2309	7157
34771123	Positive_Correlation	2309	5599
34771123	Positive_Correlation	1432	2309
34771123	Positive_Correlation	2309	644914
34771123	Negative_Correlation	MESH:C085911	207
34771123	Association	MESH:D001943	207
34771123	Positive_Correlation	2309	983

